Pioneering Growth in Regulated Markets! 💊
Senores Pharma is making waves in the pharmaceutical industry with its focus on regulated markets like the US, Canada, and UK, contributing 68% to its revenue. With 55 product launches, 16 APIs, and robust strategic alliances, it’s redefining the pharma landscape! 🚀
With revenue growth of 289% from FY22-24, driven by key acquisitions, and a healthy ROE of 26% for FY24, Senores is setting new benchmarks in profitability and innovation.
Will you subscribe to this IPO? 🤔
🔗 Disclaimer: http://ow.ly/63nS50Lqple#SenoresPharma #IPOAlert #Pharma #StockMarketIndia #MotilalOswal #SenoresPharma #IPOAlert #Pharma #StockMarketIndia #MotilalOswal
Posted On: 23 Dec 2024 3:55 PM
